Skip to main content
. Author manuscript; available in PMC: 2015 Dec 30.
Published in final edited form as: Am J Surg. 2015 Jun 2;210(3):483–491. doi: 10.1016/j.amjsurg.2015.04.009

Table 3.

Outcome of epidural analgesia among patients undergoing hepatopancreatic surgery in propensity score-matched cohort*

Outcome OR (95% CI) P value
Any complication .98 (.90–1.06) .63
 Sepsis .72 (.56–.93) .01
 Wound infection 1.12 (.95–1.32) .18
 Wound complication 1.07 (.82–1.40) .62
 Postoperative hemorrhage .81 (.65–1.01) .06
 Respiratory failure .79 (.69–.91) .001
 Postoperative pneumonia .77 (.61–.98) .04
 Cardiac complication 1.01 (.83–1.23) .94
 Ileus 1.00 (.89–1.13) .99
 Liver failure .69 (.46–1.03) .07
 Thromboembolic event .98 (.73–1.33) .91
 Postoperative shock .90 (.56–1.47) .69
 Cerebrovascular accident .91 (.26–3.19) .88
 Urinary tract infection .97 (.81–1.16) .74
Prolonged length of
 hospital stay
1.12 (1.03–1.22) .01
In-hospital mortality .72 (.56–.93) .01

CI = confidence interval; OR = odds ratio.

*

Age, race, sex, hospital bed size, hospital location/teaching status, household income, operation type, surgical approach (open vs MIS), patient location by county, primary payer, and Charlson comorbidity index (conventional analgesia is used as the reference group).

Prolonged length of hospital stay is defined by greater than or equal to 10 days.